Tuesday 26th February 2019
Stem cell transplants may be the next new therapy for scleroderma
The results of a study spanning several years indicate that there may be long-term benefits of stem cell transplant in those suffering from severe scleroderma. This multi-centre study by researchers at Dartmouth, alongside other institutions, and led by Dr Jennifer Franks focused on comparing improvements in those treated with cyclophosphamide, the more conventional drug therapy for scleroderma, to those who had undergone a stem cell transplant.